Radiopharm Theranostics Limited Director Interest Changes

This report details changes in director interests for Radiopharm Theranostics Limited. Three separate notices were filed on December 19, 2025, concerning changes in director interests for Ian Turner, Paul Hopper, and Riccardo Canevari. These changes primarily involve the acquisition of unlisted options. For Ian Turner, there was an acquisition of 6,814,000 unlisted options, increasing his total options to 25,802,350. Paul Hopper acquired 18,142,000 unlisted options, bringing his total to 62,659,518. Riccardo Canevari acquired 74,338,000 unlisted options, resulting in a total of 185,287,299 options. These option acquisitions were non-cash and approved by shareholders at the Annual General Meeting on November 20, 2025. The filings do not indicate any changes in director interests related to contracts, and no trading occurred during a closed period.